Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03221543 · ClinicalTrials.gov registry record · NA
Resting Metabolic Rate Testing in Bariatric Surgery Patients
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03221543: Clinical Trial NA study, sponsored by Baylor Research Institute.
NCT03221543 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03221543, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study evaluates if measuring resting metabolic rate (the number of calories the body burns at rest) before surgery can help predict successful weight loss after surgery.
Primary Outcome
Weigh subjects using a scale
Interventions
- DEVICE ReeVue Indirect Calorimeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2023-12-25 |
| Phase | NA |
Why NCT03221543 stopped before completion
NCT03221543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which ReeVue Indirect Calorimeter is the first listed.
NCT03221543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03221543 about?
NCT03221543 is a clinical study titled "Resting Metabolic Rate Testing in Bariatric Surgery Patients". This study evaluates if measuring resting metabolic rate (the number of calories the body burns at rest) before surgery can help predict successful weight loss after surgery.
What is the current status of trial NCT03221543?
This trial is currently terminated. It is a NA study. The enrollment target is 84 participants. The study started on 2017-07-31. Estimated completion is 2023-12-25.
What interventions are being tested in trial NCT03221543?
The interventions under investigation include: ReeVue Indirect Calorimeter (DEVICE).
Who is sponsoring clinical trial NCT03221543?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03221543's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI